Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Importance of dietary salt restriction for patients with primary aldosteronism during treatment with mineralocorticoid receptor antagonists: The potential importance of post-treatment plasma renin levels.
Yoshida Y, Fujiki R, Kinoshita M, Sada K, Miyamoto S, Ozeki Y, Mori Y, Matsuda N, Noguchi T, Nakama H, Okamoto M, Gotoh K, Masaki T, Shibata H. Yoshida Y, et al. Among authors: sada k. Hypertens Res. 2023 Jan;46(1):100-107. doi: 10.1038/s41440-022-01045-5. Epub 2022 Oct 14. Hypertens Res. 2023. PMID: 36229529
Effects of esaxerenone on blood pressure, urinary albumin excretion, serum levels of NT-proBNP, and quality of life in patients with primary aldosteronism.
Yoshida Y, Fujiwara M, Kinoshita M, Sada K, Miyamoto S, Ozeki Y, Iwamoto M, Mori Y, Nagai S, Matsuda N, Noguchi T, Okamoto M, Gotoh K, Masaki T, Shibata H. Yoshida Y, et al. Among authors: sada k. Hypertens Res. 2024 Jan;47(1):157-167. doi: 10.1038/s41440-023-01412-w. Epub 2023 Sep 17. Hypertens Res. 2024. PMID: 37717115
Antihypertensive effects and changes in extracellular water content by mineralocorticoid receptor antagonists in patients with primary aldosteronism.
Matsuda N, Yoshida Y, Inobe N, Yoshimura M, Iwamoto M, Nagai S, Sada K, Noguchi T, Yonezu C, Imaishi N, Morita M, Mori Y, Miyamoto S, Ozeki Y, Okamoto M, Gotoh K, Masaki T, Shibata H. Matsuda N, et al. Among authors: sada k. Hypertens Res. 2024 Nov 14. doi: 10.1038/s41440-024-01997-w. Online ahead of print. Hypertens Res. 2024. PMID: 39543416
459 results